Uncategorized Gonorrhea became more drug resistant while attention was on COVID-19 17 Oct 2022 COVID-19 has rightfully dominated infectious disease news since 2020. However, that doesn’t mean other infectious diseases took a break. In fact, U.S. rates of infection by gonorrhea have risen during the…
Uncategorized Phage Therapy Market Size in 2022 – 2028 16 Oct 2022 “Phage Therapy” Market Insights | No of Pages120| By Application [Animal Health, Aquaculture, Agriculture, Food Industry, Human Health, Others], By Type [DsDNA Bacteriophage, ssDNA Bacteriophage, ssRNA Bacteriophage, Others]. The Phage…
Uncategorized New Publication! 14 Oct 2022 In vitro and in vivo evaluation of the biofilm-degrading Pseudomonasphage Motto, as a candidate for phage therapy Prasanth Manohar, Belinda Loh, Dann Turner, Tamizhselvi Ramasamy, Marimuthu Mathankumar, Namasivayam Elangovan, Ramesh Nachimuthu, Sebastian Leptihn https://www.biorxiv.org/content/10.1101/2022.10.12.512010v1 Abstract Infections caused by Pseudomonas aeruginosa are becoming increasingly difficult to treat due to the emergence…
Uncategorized New Publication! Phage Genome 13 Oct 2022 Complete Genome Sequence of Pseudomonas Phage Motto Authors: Prasanth Manohar, Archana Loganathan, Ramesh Nachimuthu, Belinda Loh, Long Ma, Dann Turner, Sebastian Leptihn ABSTRACT We describe the complete genome sequence of bacteriophage Motto, which infects clinical strains of Pseudomonas aeruginosa. Motto is a T1-like siphovirus related to members…
Uncategorized Host Immunity to Phage Therapy 12 Oct 2022 In a lung transplant recipient, phage therapy was associated with a T follicular helper cell response and production of neutralizing antibody. Phage therapy with bacteriophages (viruses that infect bacteria) has…
Uncategorized NIH-supported clinical trial of phage therapy for cystic fibrosis 11 Oct 2022 Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs. The trial is evaluating whether…
Uncategorized Bacteriophage-antibiotic combination therapy saves a young boy 4 Oct 2022 Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosainfection to allow liver transplantation in a toddler Nature Communications volume 13, Article number: 5725 (2022) Read here: https://www.nature.com/articles/s41467-022-33294-w
Uncategorized Modification of the immune response by bacteriophages 26 Sep 2022 Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection Scientific Reports volume 12, Article number: 15656 (2022) Abstract: There is an urgent need to develop phage therapies for multidrug-resistant bacterial infections. However, although bacteria…
Uncategorized Development of host immune response to bacteriophage 22 Sep 2022 Development of host immune response to bacteriophage in a lung transplant recipient on adjunctive phage therapy for a multidrug resistant pneumonia 10.1093/infdis/jiac368 Abstract Bacteriophage therapy is the use of viruses…
Uncategorized New publication in Nature Microbiology 16 Sep 2022 Widespread stop-codon recoding in bacteriophages may regulate translation of lytic genes Nature Microbiology volume 7, pages 918–927 (2022) https://www.nature.com/articles/s41564-022-01128-6 Abstract: Bacteriophages (phages) are obligate parasites that use host bacterial translation machinery to produce viral…